Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study

• Published in: Cancers Vol. 14; no. 3; p. 583
• Main Authors: Lai, Yung-Rung, Chang, Ya-Lan, Lee, Chiu-Hsiang, Tsai, Tung-Han, Huang, Kuang-Hua, Lee, Chien-Ying
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 24.01.2022; MDPI
• Subjects: Cohort analysis; Comorbidity; Health insurance; Hepatitis B; hepatitis B virus; Hepatitis C; hepatitis C virus; Hodgkin's lymphoma; Lupus; non-Hodgkin lymphoma; Viruses; United States > US; Europe; Taiwan; hepatitis C virus; hepatitis B virus; non-Hodgkin lymphoma
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers14030583

Hepatitis B virus (HBV) and hepatitis C virus (HCV) are associated with an increased risk of developing non-Hodgkin lymphoma (NHL); however, adequate data corroborating these associations are lacking. Therefore, a study based on the national database was performed to investigate the correlation between HBV and HCV with NHL in Taiwan. This research was a retrospective cohort study using a nationally representative database established by the Health and Welfare Data Science Center of the Ministry of Health and Welfare, Taiwan. The participants were patients with HBV and HCV, analyzed using the propensity score matching method. The study results indicated that the incidence rate of NHL (0.13%) was significantly higher than that in patients from the general population. After controlling related variables, the hazard ratio (HR) of the incidence of NHL in patients with hepatitis was 2.37 (95% CI, 1.93-2.91). Furthermore, the incidence of NHL in patients with HBV was significantly higher than in patients from the general population (HR, 2.49; 95% CI, 1.94-3.19). The incidence of NHL in patients with HCV was significantly higher than in patients from the general population (HR, 2.36; 95% CI, 1.73-3.22). This study indicated that HBV and HCV significantly increase the risk of NHL.